Rebecca A (Emmons) Gardner MD
Instructor, Pediatrics, University of Washington School of Medicine
Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-987-2106
Dr. Gardner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Pediatric Hematology/Oncology, 2006 - 2009
University of Utah HealthResidency, Pediatrics, 2003 - 2006
University of Maryland School of MedicineClass of 2003
Certifications & Licensure
TN State Medical License 2023 - 2025
WA State Medical License 2006 - 2024
ID State Medical License 2021 - 2023
UT State Medical License 2004 - 2008
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia Start of enrollment: 2012 Mar 25
- Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors Start of enrollment: 2013 Dec 01
- A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ Leukemia Start of enrollment: 2014 Feb 11
- Join now to see all
Publications & Presentations
PubMed
- Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era.Lianna J Marks, Victor Ritter, Jennifer E Agrusa, Kala Y Kamdar, Julie Rivers
Blood Advances. 2025-03-25 - 3 citationsDevelopment of ALL-Hematotox: predicting post-CAR T-cell hematotoxicity in B-cell acute lymphoblastic leukemia.Monica S Nair, Sara K Silbert, Kai Rejeski, Karilynn A Wilson, Adam J Lamble
Blood. 2025-03-13 - Locoregional Infusion of EGFR806-CAR T Cells for Recurrent or Refractory Pediatric CNS Tumors: Results of the Completed BrainChild02 Phase 1 Clinical Trial.Juliane Gust, Bonnie L Cole, Rebecca Ronsley, Ashley L Wilson, Kristy Seidel
Neuro-Oncology. 2025-03-12
Abstracts/Posters
- Clinical Experience of CAR T Cell Immunotherapy for Relapsed and Refractory Infant ALL Demonstrates Feasibility and Favorable ResponsesRebecca Gardner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Detailed Multi-Method Analysis of Bone Marrow from Pediatric Pre-B-ALL Patients Prior to CD19-CAR-T Therapy Subsequently Evidencing Overt CAR-T ResistanceRebecca Gardner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Novel CD19t T-Antigen Presenting Cells Expand CD19 CAR T Cells In VivoRebecca Gardner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Seattle Children’s Launches CureWorks, a Project Aimed at Revolutionizing Cancer Treatment for KidsJune 12th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
